Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Kiromic Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −3 vs. Q1 2022
- Shares held
- 475.0K
- −1.55M (−76.6%) vs. Q1 2022
- Total value
- $200.0K
- −$1.53M (−88.5%) vs. Q1 2022
- New holders
- 7
- 2 more added
- Sold out
- 10
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zeke Capital Advisors, LLC | 107,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 78,854 | $33.0K | 0.00% | +78,854 | New |
| Two Sigma Securities, LLC | 49,873 | $21.0K | 0.00% | +49,873 | New |
| Redmond Asset Management, LLC | 44,392 | $19.0K | 0.01% | −6,891−13.4% | Reduced |
| Geode Capital Management, LLC | 40,962 | $17.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 31,602 | $13.0K | 0.00% | +31,602 | New |
| Virtu Financial LLC | 25,970 | $11.0K | 0.00% | +25,970 | New |
| Citadel Advisors LLC | 19,694 | $9.00K | 0.00% | +9,009+84.3% | Added |
| Shay Capital LLC | 17,300 | $7.00K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,686 | $7.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 11,100 | $5.00K | 0.00% | +11,100 | New |
| WealthTrust Axiom LLC | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,285 | $4.00K | 0.00% | +10,285 | New |
| UBS Group AG | 5,155 | $2.00K | 0.00% | −15,857−75.5% | Reduced |
| Tower Research Capital LLC (TRC) | 4,920 | $2.00K | 0.00% | +4,920 | New |
| Morgan Stanley | 1,200 | $1.00K | 0.00% | −5−0.4% | Reduced |
| Wells Fargo & Company | 42 | $0 | 0.00% | +4+10.5% | Added |
| Kepos Capital LP | 0 | $0 | 0.00% | −767,000−100.0% | Sold out |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −285,028−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −106,758−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −82,175−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −73,847−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −56,111−100.0% | Sold out |
| K.J. Harrison & Partners Inc | 0 | $0 | 0.00% | −48,233−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −34,547−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |